How many institutions held OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share in Q1 2021?

109 institutional investors reported OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share for Q1 2021. Use the holders table for investor-level position and value details.

Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM)

Q: What does CUSIP 690145107 represent in this 13F holders report?

CUSIP 690145107 is the security identifier for OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share used to aggregate holder disclosures.

CUSIP: 690145107

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class: Equity / Common Stock, par value $0.001 per share
Shares outstanding: 18,616,110
Total 13F shares: 38,393,386
Share change: +977,875
Total reported value: $2,088,213,344
Price per share: $54.39
Number of holders: 109
Value change: +$50,139,442
Number of buys: 67
Number of sells: 49

Quarterly Holders Quick Answers

What is CUSIP 690145107?
CUSIP 690145107 identifies OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2021
Previous quarter: Q4 2020

Recent filing periods for CUSIP 690145107:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of OM - Outset Medical, Inc. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	34%	6,405,091	$350,560,000	—	31 Dec 2020	13F
WARBURG PINCUS LLC	13F	Company	25%	4,732,203	$268,978,000	—	31 Dec 2020	13F
D1 Capital Partners L.P.	13F	Company	25%	4,575,754	$260,086,000	—	31 Dec 2020	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	25%	4,658,295	$254,250,000	—	31 Dec 2020	13F
PERCEPTIVE ADVISORS LLC	13F	Company	15%	2,847,822	$161,870,000	—	31 Dec 2020	13F
PFM Health Sciences, LP	13F	Company	16%	2,911,207	$150,608,000	—	31 Dec 2020	13F
VANGUARD GROUP INC	13F	Company	6.8%	1,268,079	$72,078,000	—	31 Dec 2020	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	4.9%	907,759	$51,597,000	—	31 Dec 2020	13F
JPMORGAN CHASE & CO	13F	Company	4.5%	838,224	$47,645,000	—	31 Dec 2020	13F
TimesSquare Capital Management, LLC	13F	Company	4.3%	793,915	$45,126,000	—	31 Dec 2020	13F
BlackRock Finance, Inc.	13F	Company	4%	750,568	$42,662,000	—	31 Dec 2020	13F
RTW INVESTMENTS, LP	13F	Company	3.1%	585,074	$33,256,000	—	31 Dec 2020	13F
PURA VIDA INVESTMENTS, LLC	13F	Company	2.7%	503,422	$28,615,000	—	31 Dec 2020	13F
MASSACHUSETTS FINANCIAL SERVICES CO /MA/	13F	Company	1.6%	306,287	$17,409,000	—	31 Dec 2020	13F
MOORE CAPITAL MANAGEMENT, LP	13F	Company	1.3%	248,667	$14,134,000	—	31 Dec 2020	13F
MARSHALL WACE, LLP	13F	Company	1.3%	245,601	$13,961,000	—	31 Dec 2020	13F
MORGAN STANLEY	13F	Company	1.3%	244,033	$13,871,000	—	31 Dec 2020	13F
JENNISON ASSOCIATES LLC	13F	Company	1.3%	242,984	$13,811,000	—	31 Dec 2020	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	1.2%	222,518	$12,647,000	—	31 Dec 2020	13F
Blackstone Inc.	13F	Company	1.1%	200,500	$11,396,000	—	31 Dec 2020	13F
LORD, ABBETT & CO. LLC	13F	Company	1.1%	198,744	$11,297,000	—	31 Dec 2020	13F
Bellevue Group AG	13F	Company	1%	189,711	$10,783,000	—	31 Dec 2020	13F
Maven Securities LTD	13F	Company	0.94%	174,735	$10,353,000	—	31 Dec 2020	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.94%	175,000	$9,947,000	—	31 Dec 2020	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.86%	159,865	$9,086,000	—	31 Dec 2020	13F
STATE STREET CORP	13F	Company	0.84%	156,041	$8,869,000	—	31 Dec 2020	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.82%	152,119	$8,646,000	—	31 Dec 2020	13F
Iron Triangle Partners LP	13F	Company	0.81%	150,000	$8,526,000	—	31 Dec 2020	13F
Woodline Partners LP	13F	Company	0.78%	144,610	$8,220,000	—	31 Dec 2020	13F
NORTHERN TRUST CORP	13F	Company	0.68%	126,270	$7,177,000	—	31 Dec 2020	13F
ORBIMED ADVISORS LLC	13F	Company	0.67%	125,000	$7,105,000	—	31 Dec 2020	13F
JANUS HENDERSON GROUP PLC	13F	Company	0.62%	114,595	$6,514,000	—	31 Dec 2020	13F
FRANKLIN RESOURCES INC	13F	Company	0.6%	112,537	$6,397,000	—	31 Dec 2020	13F
CITADEL ADVISORS LLC	13F	Company	0.58%	107,188	$6,092,000	—	31 Dec 2020	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.56%	104,043	$5,913,000	—	31 Dec 2020	13F
Avidity Partners Management LP	13F	Company	0.54%	100,000	$5,684,000	—	31 Dec 2020	13F
Islet Management, LP	13F	Company	0.46%	85,000	$4,831,000	—	31 Dec 2020	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.44%	82,651	$4,698,000	—	31 Dec 2020	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.43%	80,400	$4,570,000	—	31 Dec 2020	13F
Pinz Capital Management, LP	13F	Company	0.39%	72,600	$4,127,000	—	31 Dec 2020	13F
Eagle Health Investments LP	13F	Company	0.39%	72,000	$4,092,000	—	31 Dec 2020	13F
Redmile Group, LLC	13F	Company	0.38%	70,000	$3,979,000	—	31 Dec 2020	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.36%	67,735	$3,850,000	—	31 Dec 2020	13F
Ensign Peak Advisors, Inc	13F	Company	0.32%	60,251	$3,425,000	—	31 Dec 2020	13F
Monashee Investment Management LLC	13F	Company	0.32%	60,000	$3,410,000	—	31 Dec 2020	13F
TIGER GLOBAL MANAGEMENT LLC	13F	Company	0.3%	55,000	$3,126,000	—	31 Dec 2020	13F
CAAS CAPITAL MANAGEMENT LP	13F	Company	0.29%	53,493	$3,041,000	—	31 Dec 2020	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.28%	52,894	$3,007,000	—	31 Dec 2020	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.28%	52,464	$2,982,000	—	31 Dec 2020	13F
S.c.a. Candriam	13F	Individual	0.28%	51,343	$2,918,000	—	31 Dec 2020	13F

Institutional Holders of Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) as of Q1 2021

As of 31 Mar 2021, Outset Medical, Inc. - Common Stock, par value $0.001 per share (OM) was held by 109 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 38,393,386 shares. The largest 10 holders included FMR LLC, Warburg Pincus LLC, PRICE T ROWE ASSOCIATES INC /MD/, D1 Capital Partners L.P., PFM Health Sciences, LP, PERCEPTIVE ADVISORS LLC, VANGUARD GROUP INC, ALLIANCEBERNSTEIN L.P., TimesSquare Capital Management, LLC, and BlackRock Inc.. This page lists 109 institutional shareholders reporting positions in this security for the Q1 2021 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders

110

Q1 2021 holders

109

Holder diff

-1

Investor	Q4 2020 Shares	Q1 2021 Shares	Share Diff	Share Chg %	Q4 2020 Value $	Q1 2021 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.